ArticleMedicina (Kaunas, Lithuania)2025

Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn's Disease: A Prospective Cohort Study.

Luis G Guijarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.